Part,  Chapter, Paragraph

 1    I,     2. 10.  2|   to their diminutive size, nanoparticles exhibit properties that
 2    I,     2. 10.  2|    reasons for this. First, nanoparticles have, relatively, a larger
 3    I,     2. 10.  2|    solubility properties.~ ~Nanoparticles, whose dimensions range
 4    I,     2. 10.  2|  occurring vs. manufactured nanoparticles, the status of micelles/
 5    I,     2. 10.  2|     Nan orange). Engineered nanoparticles are increasingly produced
 6    I,     2. 10.  2|    existing and/or foreseen nanoparticles applications in the medical
 7    I,     2. 10.  2|  Medina et al, 2007).~ ~The nanoparticles categories of main interest
 8    I,     2. 10.  2|    et al, 2007).~ ~- Carbon nanoparticles: Fullerenes, with polygonal
 9    I,     2. 10.  2|    drug carriers;~- Ceramic nanoparticles: Inorganic particles, with
10    I,     2. 10.  2|      Liposomes: lipid-based nanoparticles, largely used in pharmaceutical
11    I,     2. 10.  2| cancer imaging:~- Nanorods: nanoparticles with 1- 100 nm length, used
12    I,     2. 10.  2|  contrast agents;~- Polymer nanoparticles: Water-soluble polymer-protein
13    I,     2. 10.  2|  Metallic and supermagnetic nanoparticles: Iron-oxide nanoparticles (
14    I,     2. 10.  2|   nanoparticles: Iron-oxide nanoparticles (5-100 nm range) are used
15    I,     2. 11    |    Medina c. et al. (2007): Nanoparticles: pharmacological and toxicological
16  III,    10.  4.  2|    risk assessment of novel nanoparticles requires further attention.~ ~